Finding the safe place between the hammer and the anvil: Sounding the depth of therapeuticon

Kidney International

Volumn 88, Issue 6, 2015, Pages 1226-1228

  Thaunat, Olivier ^a,b,c  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b INSERM   (France)

^c UNIVERSITÉ DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; AZATHIOPRINE; BELATACEPT; CD45 ANTIGEN; COMPLEMENT COMPONENT C3; CORTICOSTEROID; CYCLOSPORIN A; GLUCOCORTICOID; IMMUNOGLOBULIN G; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MERCAPTOPURINE; MYCOPHENOLATE MOFETIL; TACROLIMUS;

ACUTE GRAFT REJECTION; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; ENZYME LINKED IMMUNOSPOT ASSAY; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; IMMUNOGENICITY; IMMUNOSUPPRESSIVE TREATMENT; INTERFERON GAMMA RELEASE ASSAY; KIDNEY DONOR; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAINTENANCE THERAPY; MORTALITY; PRIORITY JOURNAL; PROTEINURIA; REVIEW; SEPSIS;

EID: 84949895793     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2015.268     Document Type: Note

References (9)

1. Morris PJ. Transplantation: a medical miracle of the 20th century. N Engl J Med 2004; 351: 2678-2680
2. Fernández-Ruiz M, Kumar D, Humar A. Clinical immune-monitoring strategies for predicting infection risk in solid organ transplantation. Clin Transl Immunology [online] 2014; 3: e12
3. Dantal J, Pohanka E. Malignancies in renal transplantation: an unmet medical need. Nephrol Dial Transplant 2007; 22(Suppl 1): i4-i10
4. Serre J-E, Michonneau D, Bachy E et al. Maintaining calcineurin inhibition after the diagnosis of post-transplant lymphoproliferative disorder improves renal graft survival. Kidney Int 2014; 85: 182-190
5. Euvrard S, Morelon E, Rostaing L et al. Sirolimus and secondary skin-cancer prevention in kidney transplantation. N Engl J Med 2012; 367: 329-339
6. Rabant M, Amrouche L, Lebreton X et al. Urinary C-X-C motif chemokine 10 independently improves the noninvasive diagnosis of antibody-mediated kidney allograft rejection. J Am Soc Nephrol 2015; ASN.2014080797 (e-pub ahead of print)
7. Ling X, Xiong J, Liang W et al. Can immune cell function assay identify patients at risk of infection or rejection? A meta-analysis. Transplantation 2012; 93: 737-743
8. Hope CM, Troelnikov A, Hanf W et al. Peripheral natural killer cell and allo-stimulated T-cell function in kidney transplant recipients associate with cancer risk and immunosuppression-related complications. Kidney Int 2015; 88: 1374-1382
9. Poggio ED, Augustine JJ, Clemente M et al. Pretransplant cellular alloimmunity as assessed by a panel of reactive T cells assay correlates with acute renal graft rejection. Transplantation 2007; 83: 847-852.